Clinical trial
The Neuromodulatory Effect of Combined Transcranial Direct Current Stimulation (tDCS) with Aphasia Therapy in the Acute Phase After Ischemic Stroke
NCT03297450 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Neuromodulatory Effect of Combined Transcranial Direct Current Stimulation (tDCS) with Aphasia Therapy in the Acute Phase After Ischemic Stroke
- Lead sponsor
- University Hospital, Ghent
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- October 2, 2017
- Completion date
- March 30, 2018
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aphasia following cerebral infarction